Kow Essuman was admitted to the Medical Science Training Program (MSTP), a combined MD/PhD program at Washington University in St. Louis. Kow began his studies in the MD program at Washington University in 2012, and gained admission to the MSTP program in February 2017. He is currently defining molecular pathways that underlie the axon self-destruction program in neurons. He hopes his findings will identify novel therapeutic targets against diseases characterized by axonal degeneration. Kow is a Howard Hughes Medical Institute Medical Fellow, and a member of the Gold Humanism Honor Society. Learn more about the MSTP program here.
- Milbrandt Lab graduate student defends thesis on enzymatic function of TIR domain
- Kow Essuman wins 2019 O’Leary Prize
- Milbrandt and DiAntonio labs publish paper on gene therapy for peripheral nerve damage in mice
- Kow Essuman named a Spencer T. and Ann W. Olin Medical Science Fellow
- Milbrandt lab postdoc publishes paper on axon survival factors